Refine your search

Search

    Filter by

    Location
      Age (years)
      Sex

      Show filters

      Pneumococcal vaccine study for toddlers 12 to 15 months old

      We’re working closely with pediatricians and researchers to expand protection for toddlers against pneumococcal disease.

      Learn more

      Sickle Cell Disease clinical trial

      The DREAM study is exploring whether a study medicine can reduce symptoms and improve the overall health of people with Sickle Cell Disease.

      Get started

      20 trials found for Breast cancer, Breast Neoplasm

      All(20)
      Recruiting(18)
      Not yet recruiting(2)
      Recruiting
      NCT03445637
      Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE®

      Breast Neoplasm

      Females
      18+ years
      1study location(s)
      Recruiting
      NCT06105632
      A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

      Advanced or Metastatic Breast Cancer

      Male or Female
      18+ years
      374study location(s)
      Recruiting
      NCT04557449
      Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

      Liposarcoma, Prostate Cancer, Breast Neoplasms, Adenocarcinoma of Lung

      Male or Female
      18+ years
      86study location(s)
      Recruiting
      NCT05226871
      Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies

      Breast Cancer, Head and Neck Cancer

      Male or Female
      18+ years
      18study location(s)
      Recruiting
      NCT04767594
      First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.

      Breast Neoplasms

      Male or Female
      18+ years
      189study location(s)
      Recruiting
      NCT04654208
      Swedish Ibrance Registries Insights (SIRI)

      Malignant Neoplasm of Breast

      Male or Female
      18 - 99 years
      1study location(s)
      Recruiting
      NCT04606446
      Study of PF-07248144 in Advanced or Metastatic Solid Tumors

      Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer

      Male or Female
      18+ years
      106study location(s)
      Recruiting
      NCT04937660
      Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC

      Metastatic Breast Cancer

      Male or Female
      18 - 90 years
      12study location(s)
      Dec 31, 2024 - Planned start date (Not yet recruiting)
      NCT04982848
      Korea Post Marketing Surveillance (PMS) Study of Talzenna®

      Breast Neoplasms

      Male or Female
      19+ years
      1study location(s)
      Sep 01, 2024 - Planned start date (Not yet recruiting)
      NCT04889495
      A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer

      Non-small Cell Lung Cancer, Metastatic Colorectal Cancer, Metastatic Breast Cancer, Metastatic Kidney Cancer, Cervical Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

      Male or Female
      19+ years
      1study location(s)

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      All(20)
      Recruiting(18)
      Not yet recruiting(2)

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.